First Trust NYSE Arca Biotechnology Index Fund
First Trust NYSE Arca Biotechnology Index Fund reported 31 holdings worth US$2.81B as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 21, 2026
First Trust NYSE Arca Biotechnology Index Fund reported 31 holdings worth US$2.81B as of Jun 30, 2026. Largest: Corcept Therapeutics Incorporated, Neogenomics, Inc. and Veracyte, Inc. Filed Aug 21, 2026 (Form N-PORT).
- Holdings
- 31
- Value as reported
- US$2.81B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Corcept Therapeutics Incorporated | 1.81M | US$157M | 5.6% |
| Neogenomics, Inc. | 9.87M | US$144M | 5.1% |
| Veracyte, Inc. | 2.44M | US$143M | 5.1% |
| Bruker Corporation | 2.02M | US$122M | 4.3% |
| Alkermes Plc | 2.28M | US$119M | 4.2% |
| Illumina, Inc. | 628K | US$110M | 3.9% |
| Krystal Biotech, Inc. | 293K | US$109M | 3.9% |
| Natera, Inc. | 393K | US$107M | 3.8% |
| Axsome Therapeutics, Inc. | 426K | US$104M | 3.7% |
| Neurocrine Biosciences, Inc. | 589K | US$99.2M | 3.5% |
| Bio-techne Corp | 1.37M | US$96.5M | 3.4% |
| Arrowhead Pharmaceuticals, Inc. | 1.17M | US$95M | 3.4% |
| Biogen Inc. | 439K | US$94.8M | 3.4% |
| Exelixis, Inc. | 1.71M | US$93.3M | 3.3% |
| Incyte Corporation | 790K | US$89.6M | 3.2% |
| Argenx Se | 94,913 | US$88.1M | 3.1% |
| Halozyme Therapeutics, Inc. | 1.12M | US$87.6M | 3.1% |
| Vertex Pharmaceuticals Incorporated | 174K | US$86.4M | 3.1% |
| Repligen Corporation | 632K | US$86.2M | 3.1% |
| Biomarin Pharmaceutical Inc. | 1.39M | US$79.6M | 2.8% |
| Amgen Inc. | 216K | US$78.3M | 2.8% |
| Genmab A/s | 269K | US$73.8M | 2.6% |
| United Therapeutics Corporation | 133K | US$71.9M | 2.6% |
| Alnylam Pharmaceuticals, Inc. | 236K | US$70.9M | 2.5% |
| Beone Medicines Ltd. Class A | 245K | US$69.8M | 2.5% |
| Gilead Sciences, Inc. | 546K | US$69M | 2.5% |
| Adma Biologics Inc | 7.82M | US$65.5M | 2.3% |
| Sarepta Therapeutics, Inc. | 3.58M | US$64.4M | 2.3% |
| Regeneron Pharmaceuticals, Inc. | 101K | US$63.2M | 2.2% |
| Moderna, Inc. | 0 | US$0 | 0.00% |
| Acadia Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related